BioCentury
ARTICLE | Finance

Party of one?

August 12, 1996 7:00 AM UTC

Beyond its dominant market capitalization, Amgen Inc. enjoys a price stability not awarded to the rest of the biotech sector. This week's Ebb & Flow column on page A5 asks whether AMGN constitutes ...